Moh Tadayyon
Impact in
-
- Diabetes Treatment and Management
- Oncology top 10%
- Peptidase Inhibition and Analysis
Papers in
- Surgery 6
- Pancreatic function and diabetes 6
-
- Metabolism, Diabetes, and Cancer 4
- Peroxisome Proliferator-Activated Receptors 3
- Co-authors
- Leo Thomas (4 shared papers)Frank Himmelsbach (3 shared papers)Elke Langkopf (3 shared papers)Matthias Eckhardt (3 shared papers)Mark Michael (2 shared papers)Noel G. Morgan (4 shared papers)Michele Bortolini (1 shared paper)Martin Bopst (1 shared paper)
- Journals
- Journal of Pharmacology and Experimental Therapeutics (2 papers)Antiviral Therapy (1 paper)Expert Opinion on Investigational Drugs (1 paper)Biochemical and Biophysical Research Communications (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- GermanyUnited KingdomSwitzerland
In The Last Decade
Moh Tadayyon
12 papers receiving 997 citations
Peers
Comparison fields: 5 of 83
- Endocrinology, Diabetes and Metabolism 456
- Oncology 254
- Cellular and Molecular Neuroscience 178
- Biochemistry 57
- Molecular Biology 385
Countries citing papers authored by Moh Tadayyon
This map shows the geographic impact of Moh Tadayyon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moh Tadayyon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moh Tadayyon more than expected).
Fields of papers citing papers by Moh Tadayyon
This network shows the impact of papers produced by Moh Tadayyon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moh Tadayyon. The network helps show where Moh Tadayyon may publish in the future.
Co-authors
The 25 scholars most cited alongside Moh Tadayyon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 249 | |
| 2 | 2007 | 241 | |
| 3 | 2014 | 137 | |
| 4 | 2005 | 123 | |
| 5 | 2004 | 92 | |
| 6 | 2006 | 50 | |
| 7 | 2008 | 32 | |
| 8 | 2004 | 28 | |
| 9 | 2008 | 27 | |
| 10 | 2003 | 23 | |
| 11 | 2004 | 18 | |
| 12 | 2008 | 3 |
About Moh Tadayyon
Moh Tadayyon is a scholar working on Surgery, Molecular Biology, Endocrinology, Diabetes and Metabolism, Oncology and Cellular and Molecular Neuroscience, having authored 12 papers that have together received 1.0k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (6 papers), Diabetes Treatment and Management (4 papers), Metabolism, Diabetes, and Cancer (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Peptidase Inhibition and Analysis (3 papers), Diabetes and associated disorders (2 papers), Diet, Metabolism, and Disease (2 papers) and Neuropeptides and Animal Physiology (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (456 citations), Oncology (254 citations), Cellular and Molecular Neuroscience (178 citations), Biochemistry (57 citations) and Molecular Biology (385 citations). Moh Tadayyon has collaborated with scholars based in Germany, United Kingdom and Switzerland. Frequent co-authors include Leo Thomas, Frank Himmelsbach, Elke Langkopf, Matthias Eckhardt, Mark Michael, Noel G. Morgan, Michele Bortolini, Martin Bopst, Matthew B. Wright and Stephen A. Smith. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Antiviral Therapy, Expert Opinion on Investigational Drugs, Biochemical and Biophysical Research Communications and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.